Dis-Chem Pharmacies Limited (JSE:DCP)
 3,390.00
 +90.00 (2.73%)
  Oct 31, 2025, 5:00 PM SAST
Dis-Chem Pharmacies Revenue
Dis-Chem Pharmacies had revenue of 19.61B ZAR in the half year ending February 28, 2025, with 20.04% growth. This brings the company's revenue in the last twelve months to 40.88B, up 7.62% year-over-year. In the fiscal year ending February 28, 2025, Dis-Chem Pharmacies had annual revenue of 39.17B with 7.96% growth.
Revenue (ttm) 
 40.88B
Revenue Growth 
 +7.62%
P/S Ratio 
 0.69
Revenue / Employee 
 2.04M
Employees 
 20,000
Market Cap 
28.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Feb 28, 2025 | 39.17B | 2.89B | 7.96% | 
| Feb 29, 2024 | 36.28B | 3.62B | 11.08% | 
| Feb 28, 2023 | 32.66B | 2.26B | 7.42% | 
| Feb 28, 2022 | 30.41B | 4.13B | 15.71% | 
| Feb 28, 2021 | 26.28B | 2.29B | 9.56% | 
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Clicks Group | 47.83B | 
| Aspen Pharmacare Holdings | 43.36B | 
| Life Healthcare Group Holdings | 26.73B | 
| Netcare | 25.85B | 
| Adcock Ingram Holdings | 9.76B | 
| AfroCentric Investment Corporation | 8.48B | 
| Ascendis Health | 734.49M | 
| Labat Africa | 198.85M | 
Dis-Chem Pharmacies News
- 1 year ago - Dis-Chem Pharmacies Ltd (JSE:DCP) Half Year 2025 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 1 year ago - Half Year 2025 Dis-Chem Pharmacies Ltd Earnings Call Transcript - GuruFocus
- 1 year ago - Dis-Chem versus Clicks - Daily Investor